chrX-5892908-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_181332.3(NLGN4X):c.2360C>T(p.Thr787Met) variant causes a missense change. The variant allele was found at a frequency of 0.000241 in 1,209,295 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T787T) has been classified as Uncertain significance.
Frequency
Consequence
NM_181332.3 missense
Scores
Clinical Significance
Conservation
Publications
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- autism, susceptibility to, X-linked 2Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN4X | NM_181332.3 | c.2360C>T | p.Thr787Met | missense_variant | Exon 6 of 6 | ENST00000381095.8 | NP_851849.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000162 AC: 18AN: 111005Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000218 AC: 40AN: 183527 AF XY: 0.000250 show subpopulations
GnomAD4 exome AF: 0.000249 AC: 274AN: 1098233Hom.: 0 Cov.: 32 AF XY: 0.000253 AC XY: 92AN XY: 363591 show subpopulations
GnomAD4 genome AF: 0.000162 AC: 18AN: 111062Hom.: 0 Cov.: 22 AF XY: 0.000210 AC XY: 7AN XY: 33278 show subpopulations
ClinVar
Submissions by phenotype
not provided Benign:2
NLGN4X: BS2 -
- -
not specified Uncertain:1
- -
Autism, susceptibility to, X-linked 2 Uncertain:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at